Rivaroxaban Does Not Alter Carotid Plaque Echolucency, Volume, or Neovascularisation
In patients with peripheral arterial disease and echolucent carotid plaques, treatment with rivaroxaban did not alter carotid plaque echolucency, volume, or IPN.
Authors
- Henrik Sillesen (ORCID: https://orcid.org/0000-0002-3302-6288)
- Karin
- Antoine Collet-Billon
- Nikolaj Eldrup (ORCID: https://orcid.org/0000-0002-7980-5295)
- Majken Lyhne Jessen (ORCID: https://orcid.org/0000-0002-0763-1898)
- Jonas Eiberg (ORCID: https://orcid.org/0000-0002-7930-3842)
Institutions
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Copenhagen Academy for Medical Education and Simulation (DK)
- Philips (France) (FR)
Publication Details
- Journal
- European Journal of Vascular and Endovascular Surgery
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1016/j.ejvs.2025.10.056
- Citations
- 1
- Primary Topic
- Cerebrovascular and Carotid Artery Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.52